U.S. pharma giant copyright scrapped two experimental weight loss supplements past yr—a when-each day tablet, lotiglipron, on account of elevated liver enzymes plus a twice-each day tablet, danuglipron, due to strong Unintended effects—but CEO Albert Bourla has explained the company is determined to “Perform and get” inside the weight probl